DIFFERENTIATION OF NEUROBLASTOMA CELLS IN CULTURE
- 1 May 1975
- journal article
- review article
- Published by Wiley in Biological Reviews
- Vol. 50 (2) , 129-165
- https://doi.org/10.1111/j.1469-185x.1975.tb01055.x
Abstract
Summary: 1. An elevation of the intracellular level of cyclic AMP in neuroblastoma cells by prostaglandin E1 by an inhibitor of cyclic AMP phosphodiesterase, or by analogues of cyclic AMP irreversibly induces many differentiated functions which are characteristic of mature neurones. These include formation of long neurites, increase in size of soma and nucleus associated with a rise in total RNA and protein contents, increase in activities of specific neural enzymes, loss of malignancy, increase in sensitivity of adenylate cyclase to catecholamines and blockade of cells in G1‐stage of the cell cycle.2. Other agents, including serum‐free medium, X‐irradiation, 6‐thioguanine, cytosine arabinoside, methotrexate, 5‐bromodeoxyuridine, nerve growth factor, glial extract and hypertonic medium can induce some of the differentiated functions which are induced by high intracellular cyclic AMP.3. Morphological differentiation and differentiated biochemical functions can each be expressed in the absence of the other.4. Many of the responses of normal embryonic nerve cells to cyclic AMP are similar to those of neuroblastoma cells.5. A working hypothesis for the malignancy of nerve cells has been proposed. This states that an abnormal regulation of cyclic AMP phosphodiesterase activity which allows the expression of high amounts of this enzyme in neuroblastoma cells, may be one of the early lesions during a malignant transformation of nerve cells.6. A new experimental therapeutic model for the treatment of neuroblastoma is proposed. This involves the administration of sodium butyrate followed by the injection of l‐dihydroxyphenylalanine (l‐dopa) and prostaglandin E1 in the presence of cyclic AMP phosphodiesterase inhibitor.7. Recent studies have elucidated the control mechanisms of some differentiated functions in neuroblastoma cells. Cyclic AMP may become an important biological tool to probe the regulation and expression of many other differentiated functions in these cells. In addition to neuroblastoma cells, other neuronal culture systems are now available for investigating the problems of differentiation and maturation in nerve cells.This publication has 103 references indexed in Scilit:
- Neuroblastoma: Drug-Induced Differentiation Increases Proportion of Cytoplasmic RNA That Contains Polyadenylic AcidScience, 1974
- Cyclic AMP levels and the morphological differentiation of mouse neuroblastoma cellsLife Sciences, 1973
- Demonstration of cholinergic cells in human neuroblastoma and ganglioneuromaThe Journal of Pediatrics, 1973
- Effect of dibutyryl cyclic AMP on nucleic acid and protein synthesis in neuronal and glial tumor cellsLife Sciences, 1972
- Neuroblastoma: Synchronization of Neurite Outgrowth in Cultures Grown on CollagenScience, 1972
- Morphological and biochemical study in X-ray- and dibutyryl cyclic AMP-induced differentiated neuroblastoma cellsExperimental Cell Research, 1972
- Adenylate cyclase and phosphodiesterase activity of normal and SV40 virus-transformed hamster astrocytes in cell cultureLife Sciences, 1971
- Transmission of Mouse Neuroblastoma by a Cell-free ExtractNature, 1970
- The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellumBiochemical and Biophysical Research Communications, 1970
- Tyrosine hydroxylase activity in neuroblastomaThe Journal of Pediatrics, 1969